We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
+14.58%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$865M
AUM Growth
+$9.54M
Cap. Flow
-$78.4M
Cap. Flow %
-9.07%
Top 10 Hldgs %
8.56%
Holding
892
New
315
Increased
150
Reduced
128
Closed
299

Top Buys

Rank Stock Value
1
XP icon
XP
XP
+$7.27M
2
STZ icon
Constellation Brands
STZ
+$7.01M
3
LLY icon
Eli Lilly
LLY
+$6.9M
4
ADP icon
Automatic Data Processing
ADP
+$6.79M
5
NU icon
Nu Holdings
NU
+$6.73M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$11.9M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$11.9M
3
MSFT icon
Microsoft
MSFT
+$11.8M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$11.7M
5
LVS icon
Las Vegas Sands
LVS
+$11.2M

Sector Composition

Rank Sector Weight
1 Technology 19.67%
2 Healthcare 18.49%
3 Consumer Discretionary 15.79%
4 Industrials 10.31%
5 Financials 10.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WAL icon
101
Western Alliance Bancorporation
WAL
$8.79B
$2.24M 0.26%
+34,073
New +$1.72M
DBRG icon
102
DigitalBridge
DBRG
$2.93B
$2.24M 0.26%
+127,780
New +$2.1M
TPR icon
103
Tapestry
TPR
$30.8B
$2.24M 0.26%
+60,753
New +$1.87M
DVN icon
104
Devon Energy
DVN
$52.1B
$2.21M 0.26%
+48,725
New +$2.23M
RS icon
105
Reliance Steel & Aluminium
RS
$20.7B
$2.2M 0.25%
7,875
+4,393
+126% +$1.17M
ACN icon
106
Accenture
ACN
$102B
$2.2M 0.25%
+6,274
New +$2.02M
SPHR icon
107
Sphere Entertainment
SPHR
$5.14B
$2.2M 0.25%
64,653
+38,271
+145% +$1.33M
RARE icon
108
Ultragenyx Pharmaceutical
RARE
$2.45B
$2.2M 0.25%
45,906
+26,831
+141% +$1.04M
SLB icon
109
SLB Ltd
SLB
$73.6B
$2.18M 0.25%
+41,930
New +$2.28M
KD icon
110
Kyndryl
KD
$2.99B
$2.18M 0.25%
+104,939
New +$1.79M
EME icon
111
Emcor
EME
$35.2B
$2.12M 0.25%
+9,842
New +$2.07M
STAA icon
112
STAAR Surgical
STAA
$1.21B
$2.12M 0.25%
67,885
+21,718
+47% +$780K
WCC
113
WESCO International
WCC
$16.7B
$2.1M 0.24%
+12,075
New +$1.81M
TER icon
114
Teradyne
TER
$57.6B
$2.1M 0.24%
19,342
-621
-3% -$58.9K
GTM
115
ZoomInfo Technologies
GTM
$973M
$2.09M 0.24%
+112,904
New +$1.77M
CNX icon
116
CNX Resources
CNX
$5.3B
$2.07M 0.24%
103,678
-35,765
-26% -$763K
ACAD icon
117
Acadia Pharmaceuticals
ACAD
$4.43B
$2.07M 0.24%
66,207
+8,908
+16% +$213K
PRTA icon
118
Prothena Corp
PRTA
$425M
$2.07M 0.24%
+56,946
New +$2.19M
AFRM icon
119
Affirm
AFRM
$23.9B
$2.06M 0.24%
+41,856
New +$1.21M
CWK icon
120
Cushman & Wakefield Ltd
CWK
$3.14B
$2.04M 0.24%
189,292
+177,903
+1,562% +$1.48M
NYT icon
121
New York Times
NYT
$12.1B
$2.01M 0.23%
+41,200
New +$1.82M
DKNG icon
122
DraftKings
DKNG
$11.6B
$2.01M 0.23%
56,936
-87,641
-61% -$2.93M
LOGI icon
123
Logitech
LOGI
$14.7B
$2.01M 0.23%
21,105
+3,360
+19% +$276K
MNDY icon
124
monday.com
MNDY
$3.68B
$2M 0.23%
10,643
+4,252
+67% +$684K
FOLD
125
DELISTED
Amicus Therapeutics
FOLD
$1.99M 0.23%
140,581
+106,541
+313% +$1.21M
3 4
5
6 7

Similar funds

PP
Pegasus Partners Mequon, Wisconsin $1.07B AUM 32.32% 1-Year Est. Return
ECM
Ensemble Capital Management San Francisco, California $1.18B AUM 41.81% 1-Year Est. Return
GCAC
Guardian Capital Advisors (Canada) Toronto, Ontario, Canada $1.02B AUM 25.29% 1-Year Est. Return
CAM
ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return
D
Diversified Wilmington, Delaware $911M AUM 31% 1-Year Est. Return
GFS
GYL Financial Synergies West Hartford, Connecticut $1.33B AUM 34.46% 1-Year Est. Return
FTIS
First Trust Investment Solutions Naples, Florida $888M AUM 34.3% 1-Year Est. Return
AIA
Alera Investment Advisors Deerfield, Illinois $851M AUM 29.76% 1-Year Est. Return

Seven Eight Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Seven Eight Capital held 892 positions worth $865M, up 1.1% from $855M the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.

Seven Eight Capital withdrew a net $78.4M in Q4 2023, closing 299 positions and reducing 128 holdings. Its most notable exit was Merck, an estimated $11.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Seven Eight Capital opened a new position in XP worth $8.3M.

  • Seven Eight Capital's largest Q4 2023 buy was XP: 318,542 shares worth $8.3M.
  • Seven Eight Capital added most to Constellation Brands in Q4 2023, an estimated $7.01M increase.
  • Seven Eight Capital's biggest Q4 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $11.9M.
  • Seven Eight Capital fully exited Merck in Q4 2023, selling an estimated $11.9M.
  • Seven Eight Capital's ten largest holdings make up 8.6% of its $865M portfolio in Q4 2023.
  • Seven Eight Capital opened 315 new positions and closed 299 in Q4 2023.
  • Seven Eight Capital's portfolio value rose 1.1% quarter-over-quarter to $865M.

Based on Seven Eight Capital's 13F filing for Q4 2023, filed 13 Feb 2024.